glaucoma, diabetic retinopathy, macular degeneration, choroidal degenerative disease, early stage age-related maculopathy, uvatis, retinal vein occlusion, retinal artery occlusion, strabismic amblyopia, primary macroglobulinemia, multiple myeloma, polycythemia vera, chronic myeloid leukemia, essential thrombocytosis, hypertension, dyslipidemia, systemic lupus erythematosus, etc."
Conditions
Sponsors
Department of Ophthalmology & Visual Sciences, Kyoto University Graduate School of Medicine
CANON INC.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patient 1) Male or female older than 20 years-old 2) patients with: glaucoma, diabetic retinopathy, macular degeneration, choroidal degenerative disease, early stage age-related maculopathy, uvatis, retinal vein occlusion, retinal artery occlusion, strabismic amblyopia, primary macroglobulinemia, multiple myeloma, polycythemia vera, chronic myeloid leukemia, essential thrombocytosis, hypertension, dyslipidemia, systemic lupus erythematosus, etc. 3) Subjects who sign an informed consent form to participate in the clinical study
Exclusion criteria
Exclusion criteria: 1) Having any side-effects (hypersensitivity, rised intraocular pressure etc.) against mydriatics 2) Revealed narrow angle by slit-lamp examination 3) Subjects who a doctor in attendance declares ineligible for any reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Comparisons between healthy subjects and patients;photoreceptor density, photoreceptor arrangement regularity, capillary image, blood flow velocity, etc. 2) Comparison between AOSLO and other fundus imaging devices (OCT, etc.); clinical findings of images and image analysis data 3) Comparison of the defference of physical charactaristics;image quality | — |
Countries
Japan
Contacts
Public ContactYuki Muraoka
Kyoto University Graduate School of Medicine Ophthalmology & Visual Sciences
Outcome results
None listed